Publications by authors named "Deborah Blumenthal"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,509

Total Likes

603

Extended Reach

8,000,823

Social Features

213
V
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, Deborah T Blumenthal, Katherine B Peters

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, Matthias Preusser, Katherine B Peters, Deborah T Blumenthal

Neuro Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.
Henning Zelba, Borong Shao, Armin Rabsteyn, Annekathrin Reinhardt, Carsten Greve, Deborah T Blumenthal

J Immunother Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Deborah T Blumenthal

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine, Deborah T Blumenthal

Lancet Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Anirban Das, Nicholas R Fernandez, Adrian Levine, Vanessa Bianchi, Lucie K Stengs, Deborah T Blumenthal

Cancer Discov· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaborative privacy-preserving analysis of oncological data using multiparty homomorphic encryption.
Ravit Geva, Alexander Gusev, Yuriy Polyakov, Lior Liram, Oded Rosolio, Deborah T Blumenthal

Proc Natl Acad Sci U S A· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.
Michal Nisnboym, Sarah R Vincze, Zujian Xiong, Chaim T Sneiderman, Rebecca A Raphael, Deborah T Blumenthal

Cancer Res Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-free dynamic contrast-enhanced MRI analysis: differentiation between active tumor and necrotic tissue in patients with glioblastoma.
Idan Bressler, Dafna Ben Bashat, Yuval Buchsweiler, Orna Aizenstein, Dror Limon, T Deborah Blumenthal

MAGMA· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state.
Eliya Shachar, Shira Peleg Hasson, Deborah T Blumenthal, Meerav Fraenkel, Yoel Uri

Acta Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Daniela A Bota, Thomas H Taylor, Naomi Lomeli, Xiao-Tang Kong, Beverly D Fu, Deborah T Blumenthal

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.
Anirban Das, Sumedha Sudhaman, Daniel Morgenstern, Ailish Coblentz, Jiil Chung, Deborah T Blumenthal

Nat Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, Justin D Lathia, Mitchell Machtay, Deborah T Blumenthal

J Neurooncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.
Carol Durno, Ayse Bahar Ercan, Vanessa Bianchi, Melissa Edwards, Melyssa Aronson, Deborah T Blumenthal

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis.
Ohad Regev, Vladimir Merkin, Deborah T Blumenthal, Israel Melamed, Tehila Kaisman-Elbaz

Neurooncol Pract· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene.
Lisa A Cannon-Albright, James M Farnham, Jeffrey Stevens, Craig C Teerlink, Cheryl A Palmer, Deborah T Blumenthal

Neuro Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis.
Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T Blumenthal

Ther Adv Med Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
Nadav Sarid, Felix Bokstein, Deborah T Blumenthal, Ahuva Weiss-Meilik, Lili Gibstein

J Neurooncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice.
Wenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, Sied Kebir, Rimas V Lukas

J Neurooncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Robert H Press, Sarah L Shafer, Renjian Jiang, Zachary S Buchwald, Mustafa Abugideiri, Deborah T Blumenthal

Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Wenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, Sied Kebir, Rimas V Lukas

J Neurooncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Andrew J Brenner, Katherine B Peters, James Vredenburgh, Felix Bokstein, Deborah T Blumenthal

Neuro Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study.
Felix Bokstein, Deborah Blumenthal, Dror Limon, Carmit Ben Harosh, Zvi Ram

Front Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability of dynamic contrast enhanced v parameter in healthy subjects and patients with brain tumors.
Moran Artzi, Gilad Liberman, Deborah T Blumenthal, Felix Bokstein, Orna Aizenstein

J Neurooncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis